Institutional investors control 0.45% of the outstanding shares in BAYRY. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Other industry. Additionally, during the quarter ended December 2012, these large investors purchased a net $2.7 million shares.
| Other institutional | 0.35% |
| Mutual fund holders | 0.10% |
| Individual stakeholders | -- |